Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

NCT06723405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (AD)
Eczema
Eczema Atopic Dermatitis

Interventions

BIOLOGICAL: EVO301
BIOLOGICAL: Placebo

Sponsor

Evommune, Inc.